Integral Derivatives’s Flowserve FLS Stock Holding History

Integral Derivatives’s Portfolio FLS Stock Details FLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-28,500	Closed	-$1.61M	–	1153
2015 Q1	$1.61M	Buy	28,500 +12,000	+73%	+$696K	0.03%	346
2014 Q4	$987K	Buy	+16,500	New	+$1.05M	0.02%	672

Other funds holding FLS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

SAM

Southernsun Asset Management Memphis, Tennessee $690M AUM 30.68% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Integral Derivatives's FLS Position: Q2 2015 in Review

Integral Derivatives sold out of Flowserve (FLS) in Q2 2015, closing a stake of 3,900 shares — an estimated $220K sold.

Integral Derivatives first reported a position in FLS in Q1 2015 and held it in 1 quarter. The position peaked at $220K in Q1 2015. 455 funds tracked by Wall St. Rank hold FLS as of Q2 2015.

Integral Derivatives reported no remaining Flowserve position as of Q2 2015 after selling out during the quarter.
Integral Derivatives sold 3,900 Flowserve shares in Q2 2015, an estimated $220K.
Integral Derivatives first reported a position in Flowserve in Q1 2015 and held it in 1 quarter.
Integral Derivatives's Flowserve position peaked at $220K in Q1 2015.
455 funds tracked by Wall St. Rank held Flowserve as of Q2 2015.

Based on Integral Derivatives's 13F filing for Q2 2015, filed 15 Jul 2015.